Manufacturing countries

Where pharmaceutical manufacturing sites are

Physical locations of drug establishments registered with the US FDA: 9,706 sites in the 36 countries below (each with at least five published sites), 2,356 of them registered for API manufacture. Countries with fewer sites are counted in the open dataset. Country is the site address, not the owner's headquarters. Sites serving only non-US markets are not in this register, so these are US-facing counts, not global capacity.

Looking for companies by headquarters instead? See the company directory.

CountryFDA-registered sitesAPI manufactureIdentified registrantsSites with current EU/UK GMP match
India1,039553666185
China1,12150198585
United States5,3084963,00063
Italy17789116141
Germany24585193158
Japan1488310134
France18764137102
Spain1415811371
United Kingdom1504311482
South Korea152421391
Switzerland109418673
Canada203351731
Ireland79346149
Netherlands49234040
Mexico8721781
Israel43203519
Denmark31202025
Taiwan5516504
Belgium48163923
Austria34132224
Singapore30122510
Brazil3011272
Czech Republic25102014
Hungary111093
Sweden2691820
Argentina149136
Poland218175
Australia385360
Turkey305280
Finland17599
South Africa9592
Norway8563
Portugal183159
Malta7366
Romania6256
Greece101106

Countries with at least five published sites. Source: FDA Drug Establishments Current Registration Site; GMP matches from EudraGMDP and MHRA GMDP. Methodology · download this table

Published sites in other countries

Countries with fewer than five published sites have no dashboard; their 50 sites are listed here.

Bangladesh

Bulgaria

Chile

Congo - Brazzaville

Costa Rica

Croatia

Dominican Republic

Estonia

Hong Kong

Iceland

Jordan

Latvia

Lithuania

Macau

Malaysia

New Zealand

Oman

Paraguay

Puerto Rico

Rwanda

Serbia

Slovakia

Slovenia

Thailand